Join Now | Print Page | Contact Us
Stakeholder Council

Stakeholder Council

The CCOI Stakeholder Council plays a crucial role in expediting innovation of ophthalmic medical technology around the globe. CCOI has grown into a forum where public and private sector members proactively work together to identify and overcome the key obstacles to ophthalmic medical product innovation. Participants include all stakeholders in the medical product ecosystem. The members include regulatory agencies, patient advocacy organizations, physicians and other providers and their professional societies, the medical industry, academia, payors, public-private partnerships, research organizations, bioethicists, and foundations. CCOI’s work is enhanced by integrating different perspectives, expertise, and resources. CCOI addresses challenges where unilateral efforts may be ineffective. Broadly incorporating stakeholder voices prevents redundancies and optimizes efforts. Our goal is to spearhead solutions to challenges that prevent innovative ophthalmic products from reaching patients around the world.

To learn how to get involved, please contact CCOI Executive Secretary Deborah O’Keefe at 571.513.6880 or by email.

Stakeholder Council Members

Abbvie, E. Randy Craven, MD FACS
Advanced Medical Technology Association (AdvaMed), Janet Trunzo, BS MS
AEYE Health, Zack Dvey-Aharon, PhD
Alcon, Kendra Hileman, PhD
American Academy of Ophthalmology, Prem S. Subramanian, MD PhD
American Academy of Ophthalmology, Verana Health, David W. Parke II, MD
American Glaucoma Society, Carla J. Siegfried, MD
American Journal of Ophthalmology Journal / University of Miami Miller School of Medicine, Richard K. Parrish II, MD
American Macular Degeneration Foundation, Matthew Levine, MA
American Society of Cataract and Refractive Surgeons, Amanda Wiegrefe, MS
American Society of Cataract and Refractive Surgeons, Elizabeth Yeu, MD
Apellis Pharmaceuticals, Alex McKeown, PhD
Association for Research in Vision & Ophthalmology, Iris Rush, CAE
Astellas Pharma, Michael Mbagwu, MD
Bascom Palmer Eye Institute, Ranya Habash, MD
Bausch & Lomb, Yehia Hashad, MD
Bausch & Lomb, Chuck Hess, BS
BrightFocus Foundation, Diane Bovenkamp, PhD
BVI Medical, Shervin J. Korangy, BS
Carl Zeiss Meditec USA, Inc, Paul Swift, MS
College of Medicine, Rangsit University, Rajavithi Hospital, Paisan Ruamviboonsuk, MD
Congressionally Directed Medical Research Programs, Quntian (Tian) Wang, PhD
Digital Diagnostics, Katherine Fairchild, MLA
Dompé, Georgea Pasedis, PharD PRh
Duke University, Sina Farsiu, PhD
EssilorLuxottica, Norbert Gorny, PhD
European Society of Cataract & Refractive Surgeons, Kristine Morrill, BS
European Vision Institute Clinical Research Network, European Vision Institute, José Cunha-Vaz, MD PhD
European Vision Institute Clinical Research Network, European Vision Institute, Hendrik P.N. Scholl, MD MA FARVO
Eyecelerator Innovation Meetings, Gilbert H. Kilman, MD
Eyenuk Inc, Gaurav Agarwal, MS
Eyenuk Inc, Christy Coyne, BS
Eyenuk Inc, Marcus Isom, BASc
Eyenuk Inc, Chaithanya Ramachandra, PhD
Eyenuk Inc, Gregg Russell, PhD
FFB & Ocular Therapeutics, Adrienne Graves, PhD
Filomena Ribeiro, Filomena J. Ribeiro, MD PhD FEBO
Foundation Fighting Blindness, Jeff Klaas, BS
Genentech, Daniela Ferrara, MD PhD FASRS
Glaucoma Research Foundation, Thomas Brunner, MBA
Healthcare AI Coalition, Cybil Roehrenbeck, JD
Imperial College London, Francesca Cordeiro, PhD MBBS
InFocus Capital Partners, Robert Rothman, PhD
International AI in Ophthalmology Society, The European Vision & Eye Research Association, Andrzej Grzybowski, MD PhD
Johnson & Johnson Vision, Rajesh K. Rajpal, MD
USC Keck School of Medicine, Linda A. Lam, MD MBA
Lavelle Fund for the Blind, Susan Olivo, MBA
Lighthouse Guild International, Calvin W. Roberts, MD
Mary Tyler Moore Vision Initiative, S. Robert Levine, MD
Massachusetts General Hospital, Jessica Kelemen, BA
Massachusetts General Hospital, Brown University, VA Providence Healthcare, Leigh R. Hochberg, MD PhD
Medical Device Manufacturers Association, Mark B. Leahey, MBA
Medical Enterprise Technology Consortium, Lauren Palestrini, PhD
MedTech Strategy Advisors, LLC and MedTech Color, Nana O. Hanafi, MSc MPH
Microsoft, David Rhew, MD
Morgenstern Center for Orbital and Facial Plastic Surgery, Kenneth E. Morgenstern, MD FACS
National Alliance for Eye and Vision Research, Dan Ignaszewski, BA
Neuralink, Daniel L. Adams, PhD
Neurali, Joseph O'Doherty, PhD
Neuralink, DJ Seo, PhD
Omni Eye & Vision and LV Prasad Eye Institute, Amit Mathur, OD
Ophthalmic Innovation Source (OIS), Emmett Cunningham Jr, MD, PhD
Orbis International, Noelle Whitestone, BS
Prevent Blindness, Kira Baldonado, MPH
Public Health, Dept Social Medicine, University of Osaka, Ryo Kawasaki, MD PhD
Queen's University Belfast, Tunde Peto, PhD
Regeneron, Farshid Sepehrband, PhD MSEE
Research to Prevent Blindness, Brian F. Hofland, PhD
The Glaucoma Foundation, Elena Sturman, BA
The Hong Kong Polytechnic University, Mingguang He, MD
Topcon Healthcare, Mary Durbin, PhD
Topcon Healthcare, Juho Uotila, BS
Tsinghua Medicine, Tsinghua University; Singapore National Eye Center, Tien Yin Wong, MPH PhD
Tufts University School of Medicine and Help Me See, Inc, Bonnie An Henderson, MD
TVST Journal / Rutgers University, Marco A. Zarbin, MD PhD FACS
ULS Santa Maria, Luis Alexandre Pereira Abegão Pinto, MD PhD
Universitaetsklinikum Giessen and Marburg GmbH, Birgit Lorenz, MD PhD
University Hospital of Antwerp, Marie-José Tassignon, MD PhD FEBOS-CR
University of California San Francisco, Frank Brodie, MD MBA
University of Iowa, Tina Hendricks, MD
University of Iowa, Erin M. Shriver, MD FACS
University of Miami, American Society of Ophthalmic Plastic and Reconstructive Surgery, Sara Tullis Wester, MD FACS
University Vita-Salute San Raffaele, M. Francesco Bandello, MD FEBO
US Navy, Gabriel Valerio, MD
Verana Health, Sujay Jadhav, MBA
Verily Life Sciences LLC, Sam Kavusi, PhD
Vision Center of Excellence, Mariia Viswanathan, MD PhD
Zeiss Group Global, Andrew Chang, BS
Zeiss Group Global, Benjamin Kaminski, PhD